Although some evidence suggests that serum VEGF changes may be more useful than plasma VEGF in cancer patients for prognosis [83], the current evidence could not conclude whether plasma or serum is a more ideal specimen for monitoring VEGF changes with exercise in older adults. This evidence concerns the gene VEGFA and cancer.